BioHair X® is a physician-directed topical formulation developed through years of research and refinement—guided by the biology of the hair follicle, not cosmetic trends.
DISCOVER OUR APPROACH →Prescription product. Available only through a qualified healthcare professional.
Hair follicles respond to intricate signaling pathways. BioHair X® was developed around pharmaceutical ingredients investigated for distinct biological mechanisms, with clinical decision-making left to qualified prescribers.
Research into prostaglandin signaling, JAK pathways, and the biology of the hair cycle informs our development approach.
From our early minoxidil-containing formulation to a newer bimatoprost-centered approach, the product has evolved over time.
BioHair X® is presented as a prescription formulation, not an over-the-counter cosmetic or a direct-to-consumer purchase.
BioHair began with a formulation featuring tofacitinib and minoxidil. As our development priorities changed, we moved away from conventional minoxidil and focused more closely on bimatoprost and complementary pathways.
BioHair X® reflects that evolution. Our history is part of the story—and our research continues.
EXPLORE THE SCIENCE →Hair products span very different categories. The presence of pharmacologically active ingredients does not, by itself, establish the safety or effectiveness of a finished formulation.
| BioHair X® | Latisse® | Typical cosmetic hair serum | |
|---|---|---|---|
| Product category | Prescription topical formulation | FDA-approved prescription eyelash treatment | Cosmetic; varies |
| Primary use | Physician-directed hair-loss care | Eyelash hypotrichosis | Appearance and conditioning |
| Bimatoprost | 1% (per current label) | 0.03% | Usually absent |
| Evidence for finished product | Clinical validation not established | Established for eyelashes | Varies by product |
The concentration comparison does not establish greater efficacy or safety. BioHair X® is not FDA-approved for scalp hair regrowth. Its active ingredients and combination require appropriate medical and regulatory review.
For patient inquiries, clinical information, and physician collaboration.
CONTACT OUR TEAM →